J Korean Neurol Assoc.  2021 Feb;39(1):1-9. 10.17340/jkna.2021.1.1.

Peripheral Neuropathy and Pain Caused by Cancer Chemotherapy

Affiliations
  • 1Department of Neurology, Konkuk University Medical Center, Seoul, Korea

Abstract

Peripheral neuropathy and pain are common adverse effects of chemotherapy, which incidence are rising significantly commensurate with extension of survival period in cancer patients. Chemotherapy-induced peripheral neuropathy is caused by most commonly used chemotherapeutic agents including platinum compounds, taxenes, proteasome inhibitors, thalidomide, and vinca alkaloids. Management of neuropathy and pain caused by chemotherapy is still challenging due to there is no proven therapies and preventive methods. The pain and its impact are becoming a main deterioration factor in quality of life and economic burden in our society. We review the mechanism, clinical characteristics, updated evidence of possible management of neuropathy and pain caused by traditional chemotherapeutic agents for contributing to the application of clinicians in their actual medical environment.

Keyword

Antineoplastic agent; Polyneuropathies; Small fiber neuropathy; Vincristine; Paclitaxel
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr